跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Madopar - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Madopar
Approved
STANDARD
Madopar
Delpharm Milano S.r.L
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
3808295659253b3d
Company
Delpharm Milano S.r.L
Type
Standard
Approval Details
Approval Id
3808295659253b3d
Drug Approval Philippines Name
Madopar
Product Name
Madopar
Registration Number
DR-XY40579
Brand Name
Madopar
Generic Name
Levodopa + Benserazide (As Hydrochloride)
Dosage Form
Tablet
Dosage Strength
200 mg/ 50 mg
Manufacturer
Delpharm Milano S.r.L
Importer
Roche (Philippines), Inc.
Distributor
Roche (Philippines), Inc.
Issuance Date
25 August 2022
Expiry Date
25 August 2027
Pharmacologic Category
Antiparkinson Drug (Dopaminergic Agent)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
3808295659253b3d
Type
Standard
Back to Philippines FDA Approvals